OFS Introduces New 200 W, 1640 nm Semi-Random Raman Laser Module

SPIE Photonics West 2025, Booth #4505– OFS, a leading innovator in fiber optic solutions, proudly announces the launch of its latest high-power product, the 200 W, 1640 nm Semi-Random Raman Laser Module. This cutting-edge module leverages OFS' expertise in Raman fiber laser technology to achieve unprecedented power levels, offering a simple yet robust solution for […]

Quantum and Space Technologies Take Center Stage during the EmTech Invest at Davos 2025

(NASDAQ:LAES),(NASDAQ:LAESV), Geneva, Switzerland, Jan. 21, 2025 (GLOBE NEWSWIRE) — WISeSat.Space and SEALSQ Achieve Breakthrough in Post-Quantum Transactions from Space SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company specializing in Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that during this year's World Economic Forum in Davos quantum technology and space exploration

OFS Introduces DataSens™ Enhanced Optical Fiber at Photonics West

Enabling longer reach and higher sensitivity for distributed fiberoptic sensing (DFOS) systems OFS, a global leader in optical fiber innovation, is excited to announce the debut of DataSens Enhanced Sensing Optical Fiber, a groundbreaking advancement in distributed fiber optic sensing (DFOS), at the prestigious Photonics West event. DataSens allows more signal to be distinguished from

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Quanterix Corporation For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or

The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against Pacira BioSciences, Inc.

LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

CSL Earns Fourth Consecutive Recognition as Top Employer for Young People

MONTREAL, Jan. 21, 2025 (GLOBE NEWSWIRE) — The CSL Group (“CSL”), a global leader in responsible marine transportation, is proud to be named one of Canada's Top Employers for Young People for the fourth consecutive year. This recognition highlights CSL's ongoing dedication to providing a dynamic and supportive environment for young professionals starting their careers

Transocean Ltd. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Transocean Ltd. ("Transocean" or "the Company") (NYSE:RIG) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by

FTAI Aviation Ltd. Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FTAI Aviation Ltd. ("FTAI Aviation" or "the Company") (NASDAQ:FTAI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated

Paladin Energy Ltd Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Paladin Energy Ltd ("Paladin" or "the Company") (OTC PINK:PALAF) for violations of the securities laws. The investigation focuses on whether the Company issued

Revance Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Revance Therapeutics, Inc. ("Revance" or "the Company") (NASDAQ:RVNC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder

Scroll to Top